Objective:
To discuss the evolution and advancements in extractable and leachable testing in the pharmaceutical industry.
Approach:
- Expert Insight: Jason Creasey, Head of Extractables & Leachables at Glaxo Smith Kline, shares insights on the historical context and advancements in testing methodologies.
Key Findings:
- The industry has evolved due to increased knowledge of contact-closure materials.
- New analytical tools, particularly those capable of high resolution accurate mass identification, have enhanced testing capabilities.
- Full scan data allows for retrospective data analysis.
Interpretation:
Conclusion:
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.